The depopulation machine is still in full gear, folks. The freaks in their white lab coats are still designing new plandemics with new deadly diseases and clot shots to go with it. Here’s the latest scoop.
A new peer-reviewed study published June 18, 2025, in Pathogens has revealed that scientists funded by the U.S. National Institutes of Health (NIH) have genetically engineered novel hybrid influenza viruses combining bat and human virus components. The research, conducted at the University of Missouri and partially funded by the NIH’s National Institute of Allergy and Infectious Diseases (NIAID), raises significant public health and biosecurity concerns.
-
- NIH-Funded Creation of Hybrid Bat-Human Influenza Viruses: Researchers at the University of Missouri, funded by NIH and CEIRR grants, engineered chimeric influenza viruses by combining bat virus genes with human H1N1 components—raising significant concerns due to their ability to replicate in mammalian cells and resist common antivirals.
-
- Engineered for Antiviral Resistance and Survival: The viruses were deliberately mutated at key sites (e.g., N31, H37, W41) to confer resistance to amantadine, a standard flu treatment, and to study how these mutations affect viral replication and survival, confirming the study’s gain-of-function nature.
-
- Pandemic Potential and Biosecurity Fears: Constructed using reverse genetics, these lab-created viruses could potentially infect humans, making them highly controversial in light of past pandemic origins linked to lab-based virus manipulation and prompting renewed biosecurity concerns.
-
- S. Taxpayer-Funded and Internationally Overseen: Despite growing public and governmental scrutiny, this research received funding from U.S. agencies including NIH/NIAID and CEIRR, with involvement from WHO-affiliated scientists and formal biosafety clearance—further fueling debate over accountability and transparency in high-risk virology.
Hellbound and Down 